Month: August 2025

JACKSONVILLE, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) — Proficient Auto Logistics, Inc. (NASDAQ: PAL) (the “Company” or “Proficient”) today reported its financial results for the three months ended June 30, 2025, and comparative summary financial information for the Founding Companies (as defined below) on a combined basis for the three months ended June 30, 2024. Second Quarter Summary (second quarter 2024 information on a combined basis) Total Operating Revenue of $115.5 million, increased 21.4% from Q1 2025 and 8.4% from Q2 2024 Total Operating Income (Loss) of $0.1 million, versus ($2.4) million in Q1 2025 and $7.0 million in Q2 2024 Adjusted Operating Income(1) of $3.8 million, versus $1.2 million in Q1 2025 and $8.7 million in Q2 2024 Adjusted Operating Ratio(1) of 96.7% compared to 98.7% in Q1 2025 and 91.8% in Q2 2024 Total...

Revenues of $109.8 million compared to $95.9 million in the prior year period Pretax income of $7.0 million compared to $6.7 million in the prior year period Record high shareholder’s equity- first time over $300 million New contract purchases of $433.0 million in the quarterLAS VEGAS, NV, Aug. 11, 2025 (GLOBE NEWSWIRE) — Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced earnings of $4.8 million, or $0.20 per diluted share, for its second quarter ended June 30, 2025. This represents an increase compared to net income of $4.7 million, or $0.19 per diluted share, in the second quarter of 2024. Revenues for the second quarter of 2025 were $109.8 million, an increase of $13.9 million, or 14.5%, compared to $95.9 million for the second quarter of 2024. Total operating expenses for the second...

FDA PDUFA goal date of August 15, 2025, for TNX‑102 SL for fibromyalgia: if approved by FDA, TNX‑102 SL would be the first new drug for fibromyalgia in more than 16 years  In June 2025, the Company was added to the Russell 3000® and Russell 2000® Indexes following the annual reconstitution Phase 3 RESILIENT results published in peer-reviewed journal, Pain Medicine, including statistically significant reduction in fibromyalgia pain with once‑nightly TNX‑102 SL; generally well tolerated Cash and cash equivalents of $125.3 million reported as of June 30, 2025; current cash runway expected to fund operations into the third quarter of 2026 CHATHAM, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biotechnology company with marketed products and a...

ROCK HILL, S.C., Aug. 11, 2025 (GLOBE NEWSWIRE) — 3D Systems Corporation (NYSE:DDD) announced today its financial results for the second quarter ended June 30, 2025.Revenue of $95 million led by double-digit growth in Medical Technology and Aerospace & Defense markets Regenerative Medicine partnership with United Therapeutics targeted on manufacture of human lungs reached a new printing milestone resulting in a $2 million award in the quarter Cost reduction and efficiency programs resulted in over $20 million of savings in operating expenses in Q2 Company’s previously announced cost initiatives are on track to support a return to positive cash flow in 2026 Successful balance sheet restructuring, combining debt retirement, refinancing, and share repurchase, allows for execution of restructuring program while maintaining continuity...

Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in China Granted orphan drug designation from the European Medicines Agency (EMA) for amezalpat for the treatment of patients with HCC Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual Meeting Granted Orphan Drug designation by FDA for TPST-1495 for the treatment of familial adenomatous polyposis (FAP)BRISBANE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today reported financial results for the quarter ended June 30, 2025 and provided a corporate update. “We...

Q2 Revenue Growth of 2.5%, Currency Neutral Growth of 1.8% Q2 Annual Subscription Revenue Growth of 3.7%, Currency Neutral 3.0% Annual Subscription Revenue Rose to 53.5% of Total Revenue in Q2 Reaffirms 2025 Revenue and Adjusted EBITDA GuidanceNEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) — Getty Images Holdings, Inc. (“Getty Images” or the “Company”) (NYSE: GETY), a preeminent global visual content creator and marketplace, today reported financial results for the second quarter ended June 30, 2025. “We delivered solid growth in the second quarter, driven by continued momentum in our subscription business and strong demand for our content and services with acceleration across Corporate, and a return to growth in Media,” said Craig Peters, Chief Executive Officer at Getty Images. “Our partnerships, unrivalled access, expertise,...

SANTA MONICA, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) — The Macerich Company (NYSE: MAC) has released its Second Quarter 2025 Earnings Results and Supplemental Information by posting it to the Investor Relations section of its website at investing.macerich.com. As previously announced, management will hold a conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) today, Monday, August 11, 2025, to discuss quarterly results. Participants who wish to join the conference by telephone must register using the dial-in registration link below to receive the dial-in number and a personalized PIN code that will be required to access the call. Participants may join the live webcast by accessing it at the webcast registration link below or in the Investors Section of the company’s website at investing.macerich.com. Participant Call-In...

Monthly Active Users Reached Approximately 88.0 million; Up 25% Year-Over-Year Record Q2 Global Net Additions of 136 thousand Paying Circles, Reaching 2.5 million TotalTotal Quarterly Revenue Increased 36% Year-Over-Year to $115.4 million Annualized Monthly Revenue Increased 36% Year-Over-Year to $416.1 millionFull-Year Outlook for Revenue and Adjusted EBITDA Raised Based on Year-To-Date Performance SAN FRANCISCO, Aug. 11, 2025 (GLOBE NEWSWIRE) — Life360, Inc. (“Life360” or the “Company”) (NASDAQ: LIF, ASX: 360), the provider of the market leading family safety and connection mobile application, today announced unaudited financial results for the second quarter (“Q2”) ended June 30, 2025. Life360 delivered record results across multiple key metrics, including Monthly Active Users (MAUs), Paying Circles, Subscription Revenue, and...

ATHENS, Greece and NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) — Heidmar Maritime Holdings Corp. (the “Company” or “Heidmar”) (NASDAQ: HMR) today reported its results for the quarter and six month period ended June 30, 2025. Second Quarter 2025 HighlightsTotal net revenue of $9.6 million, up 23% from $7.8 million in Q2 2024. Net loss attributable to shareholders from continuing operations of $0.1 million or $0.002 per share. Adjusted net income from continuing operations of $0.5 million, which excludes $0.6 million in non-cash stock-based compensation. Cash and cash equivalents of $11.3 million as of June 30, 2025 Adjusted net income from continuing operations attributable to shareholders is not a measurement recognized under US GAAP (GAAP) and should not be used in isolation or as a substitute for Heidmar’s...

Reports Net Loss of $10.4 Million or $0.24 per Diluted Share, and Adjusted EBITDA of ($9.8) Million CLAYTON, Mo., Aug. 11, 2025 (GLOBE NEWSWIRE) — FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, today announced financial results for the second quarter ended June 30, 2025. Second quarter 2025 Financial Highlights (all comparisons are with the second quarter of 2024)Revenues were $35.7 million, a decrease of 51% or $36.7 million compared to $72.4 million. Net loss was $10.4 million, or $0.24 per diluted share, down from a net income of $9.6 million, or $0.22 per diluted share. Adjusted EBITDA(1) was ($9.8) million, down from $6.9 million.Six Months 2025 Financial Highlights (all comparisons are with the first six months of 2024)Revenues were $53.2 million, a decrease...